Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders

About 1.25 million people in the UK have an eating disorder, but current treatments have limited effectiveness, prompting interest in new approaches. A web survey of 200 people with eating disorders found that 70% had used complementary therapies to manage their condition. Participants viewed psychedelic research as worthwhile but expressed moderate concern. To address these concerns, they suggested education about psychedelics and their psychiatric use, endorsement from professionals, and a safe, monitored environment with strong patient-therapist rapport. These findings inform future trials of psychedelics for eating disorders.

Study at a glance

Abstract

Approximately 1.25 million people in the UK suffer from an eating disorder, yet the treatment options show limited efficacy, warranting the need for novel approaches. This study aimed to investigate the perspectives of people with eating disorders on the use of complementary therapies and psychedelic research and treatment. Two hundred participants with eating disorders took part in this web survey study. The majority of participants (70%) had used a complementary treatment to manage their eating disorder. Participants believed that psychedelic research was worthwhile in the context of a moderate level of concern. The most popular solutions to meet these concerns included providing education around psychedelics and their effects and use in psychiatry and experiencing endorsement from professionals in the area. Moreover, participant responses emphasized the need for a safe, monitored environment and the patient-therapist rapport in the context of psychedelic treatment. The findings are explored concerning future trials of psychedelics as a treatment for eating disorders.